Hopec Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3M

  • Investors
  • 4

Hopec General Information

Description

Operator of a pharmaceutical firm intended to develop an immunotherapy treatment for bladder cancer. The company focuses on the non-muscle-invasive bladder, it employs genetically modified uropathogenic coli for targeted immune responses against cells, enabling patients to destroy cancer cells.

Contact Information

Website
www.hopec-pharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Ha-Te'ena Street
  • Giv'at Shmuel 5440101
  • Israel
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 1 Ha-Te'ena Street
  • Giv'at Shmuel 5440101
  • Israel

Hopec Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hopec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 01-Aug-2025 $3M Completed Pre-Clinical Trials
2. Seed Round 01-Jun-2024 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Hopec’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Hopec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hopec Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arieli Group Venture Capital Minority
Hadasit Venture Capital Minority
NGT HealthCare II Venture Capital Minority
Yissum Accelerator/Incubator
To view Hopec’s complete investors history, request access »

Ready to get started?

Request a free trial

Hopec FAQs

  • When was Hopec founded?

    Hopec was founded in 2023.

  • Where is Hopec headquartered?

    Hopec is headquartered in Giv'at Shmuel, Israel.

  • What is the size of Hopec?

    Hopec has 6 total employees.

  • What industry is Hopec in?

    Hopec’s primary industry is Drug Discovery.

  • Is Hopec a private or public company?

    Hopec is a Private company.

  • What is Hopec’s current revenue?

    The current revenue for Hopec is .

  • How much funding has Hopec raised over time?

    Hopec has raised $4M.

  • Who are Hopec’s investors?

    Arieli Group, Hadasit, NGT HealthCare II, and Yissum have invested in Hopec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process